Hungary's state holding company, AV Rt, will offer part of its shares in the Alkaloida Chemical plant. The price of the stake must be paid in cash, and equity of 840 million forint ($6.7 million) must be raised in order to acquire a majority stake in the company, AV Rt managing director Attila Lascsik has said. However, no minimum price will be set for the tender.
In 1994, Alkaloida reported sales of 8.4 billion forint, half of which were exports. Operating profit reached 2.3 billion forint and pretax profit for the year amounted to 1 billion forint. AV Rt expects bids from professional investors to provide new products and markets for Alkaloida.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze